Interim results of a phase II trial of first line retifanlimab (R) plus gemcitabine and docetaxel (GD) in patients (pts) with advanced soft tissue sarcoma (STS) von Rosenbaum, Evan, Qin, Li-Xuan, Dickson, Mark Andrew, Keohan, Mary Louise, Gounder, Mrinal M., Chi, Ping, Movva, Sujana, Kelly, Ciara Marie, Avutu, Viswatej, Chan, Jason Earl, Martindale, Moriah, Adamson, Travis, Clark, Camron, Desir, Rhoena, Biniakewitz, Matthew, Cho, Grace, Erinjeri, Joseph Patrick, Lefkowitz, Robert A, Tap, William D., D'Angelo, Sandra P.

Volltext